Alteration of RhoH expression is associated with human diffuse large B-cell lymphoma.

被引：0
|
作者：
Gu, Y
Alvares, CJ
Jasti, AC
Jansen, M
Bean, J
Jegga, AG
Aronow, BJ
Williams, DA
机构：
[1] Cincinnati Childrens Hosp, Res Fdn, Div Expt Hematol, Cincinnati, OH USA
[2] Univ Cincinnati, Coll Med, Dept Pathol, Cincinnati, OH USA
[3] Cincinnati Childrens Hosp, Res Fdn, Div Biostat, Cincinnati, OH USA
[4] Cincinnati Childrens Hosp, Res Fdn, Div Pediat Informat, Cincinnati, OH USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：159B / 159B
页数：1
相关论文
共 50 条
  • [21] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [22] Aberrant somatic hypermutation of follicular lymphoma transformed to diffuse large B-cell lymphoma.
    Fruehwirth, Margareta
    Deutsch, Alexander J. A.
    Staber, Philipp B.
    Aigelsreiter, Ariane
    Linkesch, Werner
    Beham-Schimid, Christine
    Neumeister, Peter
    BLOOD, 2006, 108 (11) : 683A - 683A
  • [23] Focal adhesion protein expression in human diffuse large B-cell lymphoma
    Bosch, Rosa
    Dieguez-Gonzalez, Rebeca
    Jose Moreno, Maria
    Gallardo, Alberto
    Novelli, Silvana
    Espinosa, Inigo
    Virtudes Cespedes, Maria
    Angel Pavon, Miguel
    Briones, Javier
    Granena, Albert
    Sierra, Jorge
    Mangues, Ramon
    Casanova, Isolda
    HISTOPATHOLOGY, 2014, 65 (01) : 119 - 131
  • [24] Genetic evidence of evolution from diffuse to intravascular large B-cell lymphoma.
    Zhao, XF
    Nowak, NJ
    Conroy, JM
    Bartos, JD
    Anderson, GR
    Sait, SN
    Sands, AM
    Barcos, MP
    BLOOD, 2001, 98 (11) : 237B - 238B
  • [25] Cost-effectiveness of rituximab in treatment of diffuse large B-cell lymphoma.
    Coiffier, B
    Best, JH
    Omnes, LF
    Hornberger, JC
    BLOOD, 2001, 98 (11) : 864A - 864A
  • [26] Signatures of response to the proteasome inhibitor bortezomib in diffuse large B-cell lymphoma.
    Feuerhake, F
    Monti, S
    Blank, J
    Wu, EX
    Chen, W
    Golub, TR
    Shipp, MA
    BLOOD, 2005, 106 (11) : 181A - 181A
  • [27] PRMT1 as a therapeutic target in diffuse large B-cell lymphoma.
    Goverdhan, Aarthi
    Lee, Heng-Huan
    Havranek, Ondrej
    Davis, Richard Eric
    Hung, Mien-Chie
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 42 - 42
  • [28] Significance of c-myc rearrangements in diffuse large B-cell lymphoma.
    Bierman, Philip
    Loberiza, Fausto
    Dave, Bhavana
    Sanger, Warren
    Bociek, R. Gregory
    Bast, Martin
    Vose, Julie M.
    Armitage, James Olen
    Weisenburger, Dennis
    BLOOD, 2006, 108 (11) : 575A - 575A
  • [29] Racial disparities affecting Black patients with diffuse large B-cell lymphoma.
    Ermann, Daniel Arthur
    Vardell, Victoria
    Fitzgerald, Lindsey
    Shah, Harsh
    Stephens, Deborah Marie
    Hu, Boyu
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [30] Fuzzy neural network applied to gene expression profiling for prognosis of diffuse large B-cell lymphoma.
    Suguro, M
    Ando, T
    Honda, H
    Seto, M
    BLOOD, 2002, 100 (11) : 315A - 315A
12345